Xiaohui He

4.5k citations
131 papers · 2.0k · 1 hit paper · h-index 20

Impact in

Papers in

Xiaohui He

119 papers receiving 1.9k citations

Xiaohui He's Hit Papers

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials 2018 · 341 citations
3410+2+5Years since publication100200300

Peers

Xiaohui He
Comparison fields: 5 of 104
  • Otorhinolaryngology 228
  • Pathology and Forensic Medicine 758
  • Geriatrics and Gerontology 132
  • Oncology 681
  • Immunology 254
Replace David Joske with:
David Joske Australia
Young Lyun Oh South Korea
Édouard Auclin France
Takahiro Tsushima Japan
Gloria A. Niehans United States
Süleyman Buyukberber Türkiye
Feng-Hua Wang China
Lionel D’Hondt Belgium
Yoshihiro Nabeya Japan
Xiaohui He relative to David Joske Australia David Joske's profile →
Citations per field
00.5×10×15×19×
David Joske · 1×
Citations per year

Countries citing papers authored by Xiaohui He

Since Specialization
Citations

This map shows the geographic impact of Xiaohui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui He more than expected).

Fields of papers citing papers by Xiaohui He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui He. The network helps show where Xiaohui He may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaohui He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaohui He Line = papers co-authored together Xiaohui He links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Hit paper breakdown →
2018341
2 2005279
3 2009118
4 200871
5 201964
6 201946
7 201645
8 202035
9 202035
10 202334
11 201932
12 201332
13 201630
14 200730
15 201228
16 201526
17 202124
18 201424
19 202020
20 202220

About Xiaohui He

Xiaohui He is a scholar working on Pathology and Forensic Medicine, Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 131 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (52 papers), Viral-associated cancers and disorders (19 papers), Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (8 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Malaria Research and Control (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Otorhinolaryngology (228 citations), Pathology and Forensic Medicine (758 citations), Geriatrics and Gerontology (132 citations), Oncology (681 citations) and Immunology (254 citations). Xiaohui He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shengyu Zhou, Yuankai Shi, Jianliang Yang, Liqiang Zhou, Lin Gui, Changgong Zhang, Ye‐Xiong Li, Weihu Wang, Shulian Wang and Yong-Wen Song. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Chinese Journal of Cancer, Annals of Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact